Exoskeleton leader ReWalk Robotics, Inc. (formerly Argo Medical Technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with Spinal Cord Injury (SCI). ReWalkÕs mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. Founded in 2001, ReWalk has headquarters in the US, Israel and Germany. ReWalk Robotics' ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. ReWalk is the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use ReWalk has been tested extensively in the U.S., Europe, and Israel. The ReWalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. The company offers two products: ReWalk Personal and the ReWalk Rehabilitation wearable robotic systems. The Rewalk Personal System, designed for everyday use by individuals at home and in their communities, is custom-fit for each user. The system is designed for daily use in a range of environments such as in the home, at work, at social events, indoors as well as outdoors, as well as on different surfaces or terrains. This revolutionary, cutting-edge technology allows users to stand, turn and walk with independent control of the system. The ReWalk Rehabilitation system is used in the clinical rehabilitation environment, where it provides a valuable means of exercise and therapy as well as a training base for individuals to be certified, enabling them to purchase a Personal system.